Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pneumococcal Vaccine in HIV Patients: Delayed Versus Immediate Immunization
NCT00137605Phase 2Completed
- Sponsor
- CIHR Canadian HIV Trials Network
- Start
- Sep 2004
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
Phase 2, randomised trial of 23-valent pneumococcal polysaccharide vaccine and pneumococcal 7-valent conjugate vaccine in pneumococcal infection (4 arms), sponsored by CIHR Canadian HIV Trials Network. Primary endpoint: Number of serotypes to which a response is found at 1 month. Started Sep 2004; status: completed.
02
Drugs
23-valent pneumococcal polysaccharide vaccinepneumococcal 7-valent conjugate vaccine
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT00137605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00137605.